4.6 Review

Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, Research & Experimental

Mechanism and regulation of mitophagy in nonalcoholic fatty liver disease (NAFLD): A mini-review

Lihui Zhu et al.

Summary: Mitochondrial dysfunction is central to the pathobiology of NAFLD, making maintenance of mitochondrial homeostasis crucial for treatment. Mitophagy, a process of selectively clearing damaged mitochondria through autophagy, promotes mitochondrial homeostasis. Strategies regulating mitophagy have shown promise in preclinical experiments. Traditional Chinese medicine, a natural product with active ingredients, has great potential in liver disease prevention and treatment. This review summarizes mitophagy-related pathways and the latest findings on mitophagy regulation in NAFLD, highlighting the potential of Traditional Chinese medicine.

LIFE SCIENCES (2023)

Article Gastroenterology & Hepatology

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

Maria Juarez-Fernandez et al.

Summary: This study provides evidence for the relevance of the interaction between mitochondria and microbiota in NASH and identifies targeting this interaction as a valuable therapeutic approach.

HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine

Chunxia Shi et al.

Summary: This study explored the role of trimethylamine (TMA) in nonalcoholic fatty liver disease (NAFLD) and found that TMA and its metabolite trimethylamine-N-oxide (TMAO) are closely related to NAFLD. The expression of flavin-containing monooxygenase 1 (FMO1) was increased in NAFLD, and FMO1 and its metabolite TMAO were induced by high fat and TMA. However, silencing FMO1 blocked the effects of high fat and TMA on TMAO. Furthermore, TMAO may exert its role in NAFLD through the activation of unfolded protein response (UPR).

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD

Mary P. Moore et al.

Summary: Compromised hepatic FAO and mitochondrial turnover are intimately linked to increasing NAFLD severity in patients with obesity.

HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

The fecal mycobiome in non-alcoholic fatty liver disease

Munevver Demir et al.

Summary: The study found that the fecal fungal composition of patients with non-alcoholic fatty liver disease (NAFLD) is associated with disease severity. Non-obese NAFLD patients have a distinct fungal ratio in their feces compared to other types of patients. Antifungal treatment in a mouse model can reduce liver damage from steatohepatitis.

JOURNAL OF HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

Curcumin alleviates hepatic steatosis by improving mitochondrial function in postnatal overfed rats and fatty L02 cells through the SIRT3 pathway

Susu Du et al.

Summary: Postnatal overfeeding increases the risk of NAFLD, but curcumin (CUR) can alleviate hepatic steatosis by enhancing mitochondrial function. The study found that CUR preserved mitochondrial biogenesis and antioxidant response, and upregulated SIRT3 levels in postnatal overfed rats.

FOOD & FUNCTION (2022)

Article Biochemistry & Molecular Biology

N-Acetylcysteine alleviates high fat diet-induced hepatic steatosis and liver injury via regulating the intestinal microecology in mice

Qinchao Ding et al.

Summary: N-Acetylcysteine (NAC), a well-accepted antioxidant, has been shown to protect against high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice by modulating the homeostasis of the gut microbiota. The study found that NAC supplementation improved obesity, dyslipidemia, and liver dysfunction caused by high-fat diet, and restored the disorder of the gut microbiota. The beneficial effects of NAC on NAFLD were dependent on the presence of intestinal microorganisms and involved the regulation of hepatic mRNA expression in relation to specific bacterial phyla and genera.

FOOD & FUNCTION (2022)

Article Medicine, General & Internal

Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey

Lin Guan et al.

Summary: This study investigated the incidence and characteristics of metabolic-associated fatty liver disease (MAFLD) in individuals undergoing physical examination in Liaoning Province, China. The results showed that the prevalence of MAFLD was associated with sex, cities with different economic statuses, BMI, and multiple metabolic indicators.

BMJ OPEN (2022)

Article Environmental Sciences

Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China

Qianli Yuan et al.

Summary: The prevalence and risk factors of metabolic-associated fatty liver disease (MAFLD) among adults in Beijing were investigated in this study. The results showed that the prevalence of MAFLD in Beijing adults was 32.40%, and risk factors such as male gender, older age, lower education, and urban residence were independently associated with MAFLD. Furthermore, even lean/normal-weight individuals were found to be at risk of developing MAFLD.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Genetics & Heredity

Altered Mitochondrial Quality Control in Rats with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Induced by High-Fat Feeding

Federica Cioffi et al.

Summary: This study investigates the effects of a long-term high-fat diet on mitochondrial quality control in a rodent model of metabolic dysfunction-associated fatty liver disease (MAFLD). The results show that the high-fat diet leads to increased mitochondrial reactive oxygen species production, mitochondrial DNA damage, and reduced mitochondrial biogenesis, mtDNA copy numbers, mtDNA repair, and mitochondrial fusion, as well as impaired mitophagy.
Review Biochemistry & Molecular Biology

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives

Natalia Vallianou et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, often starting as a benign liver fat accumulation that can progress to non-alcoholic steatohepatitis (NASH) and increase the risk of cirrhosis and hepatocellular carcinoma (HCC). Recent studies have highlighted the role of gut dysbiosis, which can lead to increased gut permeability and the release of toxic bacterial products and proinflammatory cytokines, causing and sustaining inflammation. The composition of the gut microbiota and various metabolites may vary during different stages of NAFLD and among population groups, and further research is needed to determine the causal relationship between gut microbiota profiles and NAFLD in patients. Additionally, multiple metabolites may contribute to the pathogenesis of NAFLD.

BIOMOLECULES (2022)

Article Gastroenterology & Hepatology

Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice

Tiphaine Le Roy et al.

Summary: The study found that the newly identified bacterium was detected in 62.7%-69.8% of the healthy population. In obese individuals with metabolic syndrome, the abundance of Dysosmobacter genus was negatively correlated with body mass index, fasting glucose, and glycated hemoglobin. In mice, supplementation with live D. welbionis J115T partially counteracted diet-induced obesity, fat mass gain, insulin resistance, and white adipose tissue inflammation.
Article Food Science & Technology

Probiotic-fermented rice buckwheat alleviates high-fat diet-induced hyperlipidemia in mice by suppressing lipid accumulation and modulating gut microbiota

Jing Yan et al.

Summary: The probiotics-fermented rice buckwheat (FRB) significantly reduced weight gain and visceral obesity, improved dyslipidemia, alleviated oxidative stress and chronic inflammation in high-fat diet-induced mice. Furthermore, FRB intervention inhibited hepatic cholesterol synthesis, promoted lipolysis, and reversed gut dysbiosis induced by high-fat diet, demonstrating its beneficial effects on hyperlipidemia.

FOOD RESEARCH INTERNATIONAL (2022)

Article Neurosciences

Gut microbiota drives age-related oxidative stress and mitochondrial damage in microglia via the metabolite N-6-carboxymethyllysine

Omar Mossad et al.

Summary: This study reveals that the gut microbiota plays a role in age-related changes in microglial gene expression and function. The absence of gut microbiota improves oxidative stress and mitochondrial dysfunction in microglia from aging brains. Additionally, the accumulation of N-6-carboxymethyllysine (CML) in microglia leads to increased reactive oxygen species and impaired mitochondrial activity and ATP reservoirs. These findings provide insights into the regulation of microglial features by the gut microbiota in aged mice and humans.

NATURE NEUROSCIENCE (2022)

Article Neurosciences

Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration

Hairong Peng et al.

Summary: A wealth of evidence suggests that gastrointestinal dysfunction is associated with Parkinson's disease (PD), but the mechanisms are not well-defined. This study reveals the importance of intestinal dopamine D2 receptor (DRD2) activity and succinate from the gut microbiome in the survival of nigral dopaminergic neurons.

NEUROSCIENCE BULLETIN (2022)

Article Multidisciplinary Sciences

Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection

Shruti Shandilya et al.

Summary: Recent studies have shown the significant impact of gut microbiota on brain functions, particularly in oxidative stress and neuroprotection. Gut bacteria metabolites play a crucial role in the pathogenesis of neurodegenerative diseases.

JOURNAL OF ADVANCED RESEARCH (2022)

Article Biochemistry & Molecular Biology

Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction-associated fatty liver disease in mice

Valeria Scalcon et al.

Summary: This study reveals the specific role of mitochondrial Grx2 in the regulation of cell metabolism and highlights an unknown association between Grx2 and metabolic dysfunction-associated fatty liver disease (MAFLD).

REDOX BIOLOGY (2022)

Article

Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease

Taiwo G. Olubodun-Obadun et al.

Drug Metabolism and Personalized Therapy (2022)

Article Biochemistry & Molecular Biology

Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD

Pia Fahlbusch et al.

Summary: The reorganization of key compounds in energy metabolism observed in the SREBP-1c animal model might explain the initial increase in mitochondrial function observed in the early stages of human MAFLD. The forced fatty liver induced a substrate limitation for oxidative phosphorylation, inducing enhanced complex II activity. The increase in mitochondrial gene expression may have indicated a counteraction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease

Raghu Ramanathan et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is a global pandemic strongly associated with metabolic syndromes. Metabolic-associated fatty liver disease (MAFLD) is suggested as a more appropriate term to describe the disease, emphasizing the role of metabolic dysfunction. Mitochondrial dysfunction plays a significant role in NAFLD development and targeting mitochondria shows promise for drug development.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

CREBH alleviates mitochondrial oxidative stress through SIRT3 mediating deacetylation of MnSOD and suppression of Nlrp3 inflammasome in NASH

Junli Zhang et al.

Summary: Lipotoxicity and unresolved oxidative stress are key drivers of metabolic inflammation in nonalcoholic steato-hepatitis (NASH). This study found that CREBH, through its association with SIRT3, alleviates mitochondrial oxidative stress and inhibits the activation of the Nlrp3 inflammasome, suggesting that CREBH may be a valuable therapeutic target for NASH.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Gastroenterology & Hepatology

Mitochondrial alterations in fatty liver diseases

Bernard Fromenty et al.

JOURNAL OF HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

Microbiome-derived ethanol in nonalcoholic fatty liver disease

Abraham S. Meijnikman et al.

Summary: This study found that microbial ethanol might contribute to pathogenesis in some patients with nonalcoholic fatty liver disease. The research suggests that microbial ethanol could be considered in the pathogenesis of this highly prevalent liver disease.

NATURE MEDICINE (2022)

Article Microbiology

Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients

Lidan Yang et al.

Summary: This study characterized the gut microbiome and overall changes in the fecal and serum metabolomes in patients with metabolic associated fatty liver disease (MAFLD). The results showed decreased species richness and diversity in the gut microbiome of MAFLD patients, as well as alterations in fecal and serum metabolites, particularly lipid molecules. The association analysis provided potential gut microbiota-metabolite combinations that could be important for further research and the development of diagnostic markers and treatments for MAFLD.

FRONTIERS IN MICROBIOLOGY (2022)

Review Nutrition & Dietetics

Gut microbiota-mitochondrial inter-talk in non-alcoholic fatty liver disease

Qi Zhang et al.

Summary: The increasing prevalence of non-alcoholic fatty liver disease (NAFLD) has become a significant healthcare burden worldwide. Recent investigations have shown that the gut microbiota plays a crucial role in the progression of NAFLD through the gut-liver axis or gut-brain-liver axis. The composition of the microbiota can be influenced by various factors, including dietary style, nutritional supplements, or exercise. Additionally, microbiota metabolites can impact mitochondrial function and inflammatory response, which are important factors in NAFLD.

FRONTIERS IN NUTRITION (2022)

Article Cell Biology

Val-Val-Tyr-Pro protects against non-alcoholic steatohepatitis in mice by modulating the gut microbiota and gut-liver axis activation

Xinshu Xie et al.

Summary: Val-Val-Tyr-Pro (VVYP) peptide has a preventive effect on non-alcoholic steatohepatitis (NASH) by modulating gut microbiota imbalance and related gut-liver axis activation. It can protect the liver by inhibiting cytotoxicity, lipid accumulation, reducing inflammation, and improving liver function.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Cell Biology

Peroxisomal Metabolite and Cofactor Transport in Humans

Serhii Chornyi et al.

Summary: This review article discusses the various modes of transport of metabolites and essential cofactors across the peroxisomal membrane, including non-selective pore-forming proteins, selective transport proteins, membrane contact sites, and shuttle systems. The focus is primarily on human peroxisomal metabolite and cofactor transport, but insights from studies in other organisms are also included.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Medicine, Research & Experimental

Role of mitochondrial dysfunction and PINK1/Parkin-mediated mitophagy in Cd-induced hepatic lipid accumulation in chicken embryos

Dawei Chen et al.

Summary: The study found that Cd exposure led to dysregulation of lipid metabolism in chicken embryo liver tissues and hepatocytes, as well as adverse effects on mitochondria, activating mitophagy through the PINK1/Parkin pathway. Inhibiting mitophagy could alleviate Cd-induced hepatic lipid accumulation, but exacerbate lipid accumulation in hepatocytes.

LIFE SCIENCES (2021)

Article Endocrinology & Metabolism

MAFLD and risk of CKD

Dan-Qin Sun et al.

Summary: This study showed that patients with MAFLD have a higher risk of CKD compared to NAFLD patients, and the severity of MAFLD is associated with CKD and abnormal albuminuria.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Multidisciplinary Sciences

Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease

Gerald J. Shami et al.

Summary: Giant mitochondria exhibit peculiar shape and large size in hepatic parenchymal cells, typically associated with cellular adversity, particularly in non-alcoholic fatty liver disease. This liver disease is the most prevalent in lipid dysmetabolism, where mitochondrial dysfunction plays a crucial role.

SCIENTIFIC REPORTS (2021)

Article Environmental Sciences

Total Nut, Tree Nut, and Peanut Consumption and Metabolic Status in Southern Italian Adults

Agnieszka Micek et al.

Summary: The study found that higher nut consumption is associated with overall better metabolic status in individuals living in Southern Italy, particularly showing a significant negative association with hypertension.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Gastroenterology & Hepatology

Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study

Yu-ling Chen et al.

Summary: MAFLD is prevalent in China and varies considerably among different age, sex, BMI, and female menopausal status groups. MAFLD is related to metabolic disorders, especially obesity, while metabolic disorders also play important roles in the occurrence of MAFLD in nonobese individuals. MAFLD patients exhibit a high prevalence of metabolic syndrome, dyslipidaemia, hyperuricaemia, and elevated liver enzymes. MAFLD tends to coexist with systemic metabolic disorders, and a deep inner relationship may exist between MAFLD and metabolic syndrome. Metabolic disorders should be considered to improve the management of MAFLD.

BMC GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD

Yu Ri Im et al.

Summary: The study found that high-fat, high-fructose diets most closely replicate the human phenotype of NAFLD, and genetic models support the role of adipose dysfunction and innate immunity in NAFLD progression. There is substantial variability in the nomenclature of animal models, highlighting the need for consensus on specialist diet terminology.

HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

Resveratrol Butyrate Esters Inhibit BPA-Induced Liver Damage in Male Offspring Rats by Modulating Antioxidant Capacity and Gut Microbiota

Jin-Xian Liao et al.

Summary: Oral administration of resveratrol butyrate ester has a protective effect against the damage caused by bisphenol A, reducing metabolic disruption and liver inflammation induced by BPA exposure, while also enhancing the barrier formed by intestinal cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Consumption of soybean or olive oil at recommended concentrations increased the intestinal microbiota diversity and insulin sensitivity and prevented fatty liver compared to the effects of coconut oil

Valeria Lopez-Salazar et al.

Summary: The study showed that consuming soybean oil rich in polyunsaturated fats benefits gut microbiota diversity, increases insulin sensitivity, and reduces inflammation. Meanwhile, consuming olive oil rich in monounsaturated fats increases Bifidobacterium levels, enhances fatty acid oxidation, and decreases inflammation.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2021)

Article Medicine, General & Internal

Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes

Roberta Zupo et al.

Summary: Screening for NAFLD is crucial for managing fatty liver, and glucose metabolism plays a significant role in monitoring the risk of NAFLD in overweight subjects without diabetes.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Biotechnology & Applied Microbiology

Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome

Xingxing Li et al.

Summary: The study found that berberine can attenuate trimethylamine-N-oxide production by modulating gut microbiota, thereby reducing atherosclerotic lesions.

NPJ BIOFILMS AND MICROBIOMES (2021)

Article Endocrinology & Metabolism

Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor

Yukina Takeichi et al.

Summary: The study demonstrates that deletion of MFF in liver induces ER stress and reduces hepatic TG secretion both in vivo and in vitro. MffLiKO mice are more susceptible to HFD-induced NASH phenotype due to ER stress-induced apoptosis of hepatocytes and suppression of TG secretion. This study provides evidence for the involvement of mitochondrial fission in the development of NASH.

DIABETOLOGIA (2021)

Review Food Science & Technology

Quercetin and non-alcoholic fatty liver disease: A review based on experimental data and bioinformatic analysis

Li Chen et al.

Summary: Quercetin, a polyphenol found in plants, has shown hepatoprotective effects against NAFLD, particularly in hepatic steatosis and hepatitis, through mechanisms such as improving fatty acid metabolism and anti-inflammation. Further research based on GEO database and experimental evidence has discussed the pathways of quercetin on NAFLD comprehensively.

FOOD AND CHEMICAL TOXICOLOGY (2021)

Article Gastroenterology & Hepatology

MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach

Tsubasa Tsutsumi et al.

Summary: The study found that MAFLD patients had a higher risk of worsening ASCVD compared to NAFLD patients. The superiority of MAFLD was attributed to metabolic dysfunction rather than moderate alcohol consumption.

HEPATOLOGY RESEARCH (2021)

Review Biochemistry & Molecular Biology

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Agostino Di Ciaula et al.

Summary: NAFLD is a common chronic liver disease that can progress to NASH, affecting liver function through various pathways and mitochondrial abnormalities, with no established treatment currently available. Mitochondria are seen as potential future therapeutic targets for improving liver bioenergetics in NAFLD/NASH.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases

Siarhei A. Dabravolski et al.

Summary: The prevalence of NAFLD is rapidly increasing globally, with cardiovascular diseases being the most common cause of mortality in NAFLD patients. Atherogenic dyslipidemia, altered fatty-acid beta-oxidation in liver mitochondria, and various NAFLD-associated genes with cardioprotective effects are key factors connecting NAFLD-mediated dyslipidemia and increased cardiovascular disease risk.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Gastroenterology & Hepatology

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Donghee Kim et al.

Summary: This study demonstrated that metabolic dysfunction-associated fatty liver disease (MAFLD) was associated with an increased risk of all-cause mortality in US adults, while non-alcoholic fatty liver disease (NAFLD) showed no association with all-cause mortality after adjusting for metabolic risk factors. Individuals who met the criteria for MAFLD but not NAFLD had a higher risk of all-cause mortality.

JOURNAL OF HEPATOLOGY (2021)

Article Multidisciplinary Sciences

High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide

Woongjae Yoo et al.

Summary: It was found that chronic exposure to a high-fat diet can increase levels of circulating trimethlamine N-oxide, a potentially harmful metabolite generated by gut microbiota.

SCIENCE (2021)

Review Biochemistry & Molecular Biology

Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates

Ashiq Khan et al.

Summary: NAFLD is a leading chronic liver syndrome globally, with gut microbiota dysbiosis significantly affecting its pathogenesis and severity. Probiotics show promising effects in alleviating gut microbiota dysbiosis and inhibiting the progression of NAFLD through the gut-liver axis.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Review Nutrition & Dietetics

A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier

Wangxin Liu et al.

Summary: Short-chain fatty acids (SCFAs) may have positive effects on inflammatory bowel disease, type 1 diabetes mellitus, and non-alcoholic fatty liver disease, and are related to gut microbiota and gut barrier health. SCFAs seem to maintain gut barrier by promoting intestinal epithelial cells growth, strengthening intestinal tight connection, and regulating gut microbiota and immune cells activities.

EUROPEAN JOURNAL OF NUTRITION (2021)

Article Biochemistry & Molecular Biology

Sodium acetate protects against nicotine-induced excess hepatic lipid in male rats by suppressing xanthine oxidase activity

E. O. Dangana et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2020)

Article Biochemistry & Molecular Biology

Dimethyl fumarate protects thioacetamide-induced liver damage in rats: Studies on Nrf2, NLRP3, and NF-κB

Durgesh K. Dwivedi et al.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)

Review Biochemistry & Molecular Biology

Alcohol effects on hepatic lipid metabolism

Sookyoung Jeon et al.

JOURNAL OF LIPID RESEARCH (2020)

Review Gastroenterology & Hepatology

Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

Shiv K. Sarin et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

Judith Aron-Wisnewsky et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Nutrition & Dietetics

PGC-1α-mediated regulation of mitochondrial function and physiological implications

Jens Frey Halling et al.

APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2020)

Article Gastroenterology & Hepatology

Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease

Sonja Lang et al.

GASTROENTEROLOGY (2020)

Review Microbiology

Microbiota and Fatty Liver Disease - the Known, the Unknown, and the Future

Sonja Lang et al.

CELL HOST & MICROBE (2020)

Article Gastroenterology & Hepatology

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Sakura Yamamura et al.

LIVER INTERNATIONAL (2020)

Review Biochemistry & Molecular Biology

Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes

Teresa Vezza et al.

ANTIOXIDANTS (2020)

Article Multidisciplinary Sciences

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease

Cyrielle Caussy et al.

NATURE COMMUNICATIONS (2019)

Review Gastroenterology & Hepatology

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)

Sebastiao M. B. Duarte et al.

ANNALS OF HEPATOLOGY (2019)

Article Biochemistry & Molecular Biology

Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease

Maria Isabel Hernandez-Alvarez et al.

Editorial Material Gastroenterology & Hepatology

Toward More Accurate Nomenclature for Fatty Liver Diseases

Mohammed Eslam et al.

GASTROENTEROLOGY (2019)

Article Biochemistry & Molecular Biology

Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease

Liang Guo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Food Science & Technology

Mitochondria-Mediated Pathogenesis and Therapeutics for Non-Alcoholic Fatty Liver Disease

Zheng Li et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2019)

Article Biochemistry & Molecular Biology

Host mitochondria influence gut microbiome diversity: A role for ROS

Tal Yardeni et al.

SCIENCE SIGNALING (2019)

Article Biochemistry & Molecular Biology

Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner

Xin Han et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2019)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease - A global public health perspective

Zobair M. Younossi

JOURNAL OF HEPATOLOGY (2019)

Review Endocrinology & Metabolism

NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?

Daniela Stols-Goncalves et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)

Review Endocrinology & Metabolism

Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease

Ze Chen et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)

Review Gastroenterology & Hepatology

Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

Wei Jia et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Lipotoxicity and the gut-liver axis in NASH pathogenesis

Fabio Marra et al.

JOURNAL OF HEPATOLOGY (2018)

Article Food Science & Technology

Frataxin-Mediated PINK1-Parkin-Dependent Mitophagy in Hepatic Steatosis: The Protective Effects of Quercetin

Peiyi Liu et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2018)

Review Gastroenterology & Hepatology

Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases

Abdellah Mansouri et al.

GASTROENTEROLOGY (2018)

Article Biochemistry & Molecular Biology

Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression

Da Zhou et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Review Gastroenterology & Hepatology

Lipid droplets and liver disease: from basic biology to clinical implications

Nina L. Gluchowski et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Review Physiology

The Crosstalk between the Gut Microbiota and Mitochondria during Exercise

Allison Clark et al.

FRONTIERS IN PHYSIOLOGY (2017)

Article Multidisciplinary Sciences

Mitochondria-targeted antioxidants as highly effective antibiotics

Pavel A. Nazarov et al.

SCIENTIFIC REPORTS (2017)

Review Gastroenterology & Hepatology

REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Julio Madrigal-Matute et al.

GASTROENTEROLOGY (2016)

Article Oncology

Mitochondrial genome architecture in non-alcoholic fatty liver disease

Silvia Sookoian et al.

JOURNAL OF PATHOLOGY (2016)

Article Multidisciplinary Sciences

High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22

Max Gulhane et al.

SCIENTIFIC REPORTS (2016)

Article Nutrition & Dietetics

Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)

Cheng Jun Jin et al.

BRITISH JOURNAL OF NUTRITION (2015)

Review Endocrinology & Metabolism

Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk

E. Angela Murphy et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2015)

Article Cell Biology

How informative is the mouse for human gut microbiota research?

Thi Loan Anh Nguyen et al.

DISEASE MODELS & MECHANISMS (2015)

Review Biochemistry & Molecular Biology

The pathways of mitophagy for quality control and clearance of mitochondria

G. Ashrafi et al.

CELL DEATH AND DIFFERENTIATION (2013)

Review Biochemistry & Molecular Biology

The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

Gijs den Besten et al.

JOURNAL OF LIPID RESEARCH (2013)

Review Cardiac & Cardiovascular Systems

The connection between inner membrane topology and mitochondrial function

Carmen A. Mannella et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)

Article Cell Biology

Bactericidal Antibiotics Induce Mitochondrial Dysfunction and Oxidative Damage in Mammalian Cells

Sameer Kalghatgi et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Article Multidisciplinary Sciences

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

Jorge Henao-Mejia et al.

NATURE (2012)

Article Medicine, Research & Experimental

Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice

Michal Aharoni-Simon et al.

LABORATORY INVESTIGATION (2011)

Review Gastroenterology & Hepatology

Mitochondrial dysfunction in nonalcoholic steatohepatitis

Gaetano Serviddio et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2011)

Article Pathology

Abnormalities in Mitochondrial Structure in Cells from Patients with Bipolar Disorder

Anne M. Cataldo et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

Article Biochemistry & Molecular Biology

Pyruvate kinase in pig liver mitochondria

Roberto Pizzuto et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)

Article Cell Biology

Long-term High-fat-diet Feeding Impairs Mitochondrial Biogenesis in Liver of Male and Female Rats

Antonia Nadal-Casellas et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)

Review Biochemistry & Molecular Biology

OXPHOS gene express ion and control in mitochondrial disorders

Fimmie Reinecke et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)

Article Medicine, General & Internal

Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model

G. Serviddio et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)

Review Biochemistry & Molecular Biology

Mitochondrial involvement in non-alcoholic steatohepatitis

Gaetano Serviddio et al.

MOLECULAR ASPECTS OF MEDICINE (2008)

Review Biochemistry & Molecular Biology

Control of mitochondrial β-oxidation flux

S Eaton

PROGRESS IN LIPID RESEARCH (2002)

Review Biochemistry & Molecular Biology

The internal structure of mitochondria

TG Frey et al.

TRENDS IN BIOCHEMICAL SCIENCES (2000)